Basta Steven L 4

What Happened
Steven L. Basta, President, CEO and Director of Phathom Pharmaceuticals (PHAT), had performance stock units vest on Feb 10, 2026. The vesting resulted in issuance of 12,362 shares to him (acquired at $0.00). To satisfy the issuer's tax withholding obligation, 6,277 of those shares were surrendered (disposed) at an attributed price of $12.82 per share, totaling $80,471.

Key Details

• Transaction date: February 10, 2026; Form 4 filed February 12, 2026 (Period of Report: 2026-02-10). Filing appears timely (within the typical 2-business-day window).
• Award: 12,362 shares issued upon vesting of performance stock units (PSUs) granted April 3, 2025 (Footnote F1).
• Tax withholding: 6,277 shares were surrendered to the company to satisfy tax withholding (Footnote F3); attributed value $12.82/share, $80,471 total.
• Other note: filing references 2,410 shares acquired under Phathom’s employee stock purchase plan in January 2026 (Footnote F2).
• Shares owned after the transaction: not specified in the provided filing.

Context
This was not an open-market sale; it was issuance of shares on PSU vesting followed by a routine share surrender to cover taxes (a common cashless settlement). Such withholding transactions are administrative and do not necessarily signal a change in the insider’s view of the company.